I've posted this so many times it's unbelievable but I'll do it again.
Rapid taper of steroids is dangerous it can kill. It is also extremely unpleasant to go thorough.
These are UK guidelines supported by the reference list below.
Gradual withdrawal should be considered for people who received more than 40 mg prednisolone daily for more than 1 week. •The problem has resolved and treatment has been given for only a few weeks. Reduce by 2.5 mg every 3–4 days, down to 7.5 mg per day, then reduce more slowly, for example by 2.5 mg every week, fortnight, or month.
•There is uncertainty about disease resolution and/or therapy has been given for many weeks. Reduce by 2.5 mg every fortnight or month down to 7.5 mg per day, then reduce by 1 mg every month.
•Symptoms of the disease are likely to recur on withdrawal Reduce by 1 mg every month.
References
ABPI Medicines Compendium (2014) Summary of product characteristics for Deltacortril 5mg Gastro-resistant Tablets.Electronic Medicines CompendiumDatapharm Communications Ltd.
www.medicines.org.uk [Free Full-text]
Arlt, W. and Allolio, B. (2003) Adrenal insufficiency.Lancet361(9372), 1881-1893. [Abstract]
Aronson, J.K. (Ed.) (2006a) Meyler's side effects of drugs. The international encyclopedia of adverse drug reactions and interactions. Volume 1: A-B.15th edn. Amsterdam: Elsevier.
Aronson, J.K. (Ed.) (2006b) Meyler's side effects of drugs. The international encyclopedia of adverse drug reactions and interactions. Volume 2: C-D.15th edn. Amsterdam: Elsevier.
Aronson, J.K. (Ed.) (2006c) Meyler's side effects of drugs. The international encyclopedia of adverse drug reactions and interactions.15th edn. Oxford: Elsevier.
Ashwood, P., Crowther, C., Willson, K. et al. (2006) Neonatal adrenal function after repeat dose prenatal corticosteroids: a randomized controlled trial.American Journal of Obstetrics and Gynecology194(3), 861-867. [Abstract]
Autio, P., Oikarinen, A., Nelkko, J. et al. (1994) Systemic glucocorticoids decrease the synthesis of type I and type III collagen in human skin in vivo, whereas isotretinoin treatment has little effect.British Journal of Dermatology131(5), 660-663. [Abstract]
Baxter, K. and Preston, C.L. (Eds.) (2013) Stockley's drug interactions: a source book of interactions, their mechanisms, clinical importance and management.10th edn. London: Pharmaceutical Press.
BNF 69 (2015) British National Formulary. 69th edn. London: British Medical Association and Royal Pharmaceutical Society of Great Britain.
Brayfield, A. (2014) Martindale: the complete drug reference.MICROMEDEX. .London: Truven Health Analytics.
Coulson, I. (1996) Topical steroids for skin disease.Dermatology in Practice4(2), 5-9.
CSM (1998) Focus on corticosteroids.Current Problems in Pharmacovigilance24(May), 5-10. [Free Full-text]
GINA (2015) Global strategy for asthma management and prevention.Global Initiative for Asthma.
www.ginasthma.org [Free Full-text]
Jameison, K. and Dinan, T.G. (2001) Glucocorticoids and cognitive function: from physiology to pathphysiology.Human Pyschopharmacology16(4), 293-302. [Abstract]
LactMed (2015) Prednisolone.National Library of Medicine.
www.toxnet.nlm.nih.gov Liu, D., Ahmet, A., Ward, L. et al. (2013) A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.Allergy, asthma, and clinical immunology9(30), 1-25. [Abstract] [Free Full-text]
London and South East Medicines Information Service, South West Medicines Information Service and Croydon Clinical Commissioning Group (2014) Suggestions for drug monitoring in adults in primary care.UK Medicines Information.
www.ukmi.nhs.uk [Free Full-text]
Menter, A., Korman, N.J., Elmets, C.A. et al. (2009) Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.Journal of the American Academy of Dermatology60(4), 643-659. [Abstract] [Free Full-text]
Micromedex (2014) MICROMEDEXTruven Health Analytics Inc.
Oren, D., Nulman, I., Makhija, M. et al. (2004) Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk?Canadian Family Physician50(), 1083-1085. [Abstract] [Free Full-text]
Peltoniemi, O., Kari, M. and Hallman, M. (2011) Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis.Acta obstetricia et gynecologica Scandinavica90(7), 19-27. [Free Full-text]
Rang, H.P., Ritter, J.M., Flower, R.J. and Henderson, G. (2015) Rang and Dale's pharmacology. 8th edn. Edinburgh: Churchill Livingstone.
Richter, B., Neises, G. and Clar, C. (2002) Glucocorticoid withdrawal schemes in chronic medical disorders: a systematic review.Endocrinology and Metabolism Clinics of North America31(3), 751-778. [Abstract]
Schaefer, C., Peters, P. and Miller, R. (Eds.) (2015) Drugs during pregnancy and lactation: treatment options and risk assessment.3rd ed. edn. London: Academic Press.
SIGN and BTS (2014) British guideline on the management of asthma: a national clinical guideline (revised 2014).Scottish Intercollegiate Guidelines Network and The British Thoracic Society.
www.sign.ac.uk [Free Full-text]
UKTIS (2012) Use of corticosteroids in pregnancy.TOXBASEUK Teratology Information Service.
www.toxbase.org Walker, R. and Whittlesea, C. (Eds.) (2011) Clinical Pharmacy and Therapeutics.5th edn. Edinburgh: Churchill Livingstone.
Topic Author
